If you're not seeing visible change by week 12 on a stable dose, the troubleshooting order above is where to look usually nutrition, training volume, or recovery before the dose itself
Unlike many current weight-loss drugs that focus mainly on GLP-1 activity, retatrutide targets three hormone pathways: GIP, GLP-1, and glucagon
The VTA, located in the midbrain, plays an important role in reward and addiction by modulating how much dopamine is sent to the NAc
Whether this is clinically preferable to more frequent, pulse-preserving dosing with Mod GRF 1-29 depends on the treatment objective a point worth discussing with a prescribing clinician
Product packaging, labeling, and appearance shown on this website are for illustrative purposes only